San Diego, CA, United States of America

K Raja Reddy

USPTO Granted Patents = 32 


 

Average Co-Inventor Count = 4.1

ph-index = 11

Forward Citations = 763(Granted Patents)


Company Filing History:


Years Active: 2000-2020

Loading Chart...
Loading Chart...
Loading Chart...
32 patents (USPTO):Explore Patents

Title: **K Raja Reddy: Innovator in Pharmaceutical Patents**

Introduction

K Raja Reddy, located in San Diego, California, is a prominent inventor known for his significant contributions to the field of pharmaceutical innovations. With a remarkable portfolio encompassing 32 patents, Raja Reddy has made substantial advancements in the treatment of metabolic disorders and conditions related to hyperlipidemia.

Latest Patents

Among his notable inventions, K Raja Reddy has developed inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1), which are crucial in treating hyperlipidemias. His first patent relates to the use of fused bicyclic heterocyclic adducts of thiohydroxy pyridines or pyrimidines as DGAT-1 inhibitors, targeting various diseases associated with lipid metabolism. These inhibitors aim to ameliorate conditions such as high postprandial triglycerides, diet-related hypertriglyceridemia, and cardiovascular risks linked to excessive triglycerides. Additionally, they show potential for combating insulin resistance and glucose intolerance, particularly in patients who are overweight, diabetic, or suffering from glucose metabolic disorders like Syndrome X and polycystic ovary disease.

Another breakthrough patent from Raja Reddy describes compounds that can also act as inhibitors of DGAT-1, identified by the formula Q-G-G-G-G-Z. This innovation echoes the aim of providing therapeutic solutions for similar health issues, further establishing his authority in the domain of metabolic disease treatment.

Career Highlights

Throughout his career, K Raja Reddy has been associated with notable companies within the pharmaceutical industry, such as Metabasis Therapeutics, Inc. and Sankyo Company, Limited. His work has significantly contributed to the understanding and treatment of lipid metabolism disorders.

Collaborations

In his journey, Raja has collaborated with esteemed professionals including Mark D. Erion and Qun Dang. These collaborations have enriched his research and led to impactful innovations in the field.

Conclusion

K Raja Reddy's extensive patent portfolio and collaborative efforts emphasize his role as a leading inventor and innovator in pharmaceutical sciences. His work on DGAT-1 inhibitors not only showcases his expertise but also highlights the potential for innovative treatments for complex metabolic disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…